Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

201. The effectiveness of mailed patient reminders on mammography screening: a meta analysis

The effectiveness of mailed patient reminders on mammography screening: a meta analysis The effectiveness of mailed patient reminders on mammography screening: a meta analysis The effectiveness of mailed patient reminders on mammography screening: a meta analysis Wagner T H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed (...) critical assessment on the reliability of the study and the conclusions drawn. Health technology Reminder systems to increase mammography screening rates. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Women aged 40 years and older who are eligible for mammography screening. Setting Community setting. This study was carried out at the School of Public Health, University of California, Berkeley, California, USA. Dates to which data relate Effectiveness

1998 NHS Economic Evaluation Database.

202. The psychosocial consequences of mammography

The psychosocial consequences of mammography The psychosocial consequences of mammography The psychosocial consequences of mammography Rimer B K, Bluman L G Authors' objectives To determine the impact of false positive mammograms and the broader psychological impact of mammography. This review focuses on the psychosocial consequences of abnormal mammograms. Some consideration of the more general mammography experience is presented in order to place reactions to abnormal mammograms in context (...) . Where published, reports about interventions to help women cope with the abnormal mammography experience are also included. The larger issue of compliance with recommended follow-up for abnormal mammograms is beyond the scope of this report. Searching Three separate searches of MEDLINE, CancerLit, and PsycINFO were performed and investigators who were conducting research in this area were contacted, without result. Study selection Study designs of evaluations included in the review Most studies were

1997 DARE.

203. Economic evaluation of a mammography-based breast cancer screening programme in Spain

Economic evaluation of a mammography-based breast cancer screening programme in Spain Economic evaluation of a mammography-based breast cancer screening programme in Spain Economic evaluation of a mammography-based breast cancer screening programme in Spain Garuz R, Forcen T, Cabases J, Antonanzas F, Trinxet C, Rovira J, Anton F Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology A mammography-based breast cancer screening programme. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population The study population comprised women between 50 and 65 years of age. Setting Secondary care. The study was carried out in Spain. Dates to which data relate The data for the effectiveness

1997 NHS Economic Evaluation Database.

204. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age

Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age Salzmann P, Kerlikowske K, Phillips K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief (...) summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening mammography for women 40-49 years. Type of intervention Screening. Economic study type Cost-effectiveness and cost-utility analysis. Study population Women of 40 years of age and older. Setting Primary care. The study was carried out in California, USA. Dates to which data relate The effectiveness data were obtained from

1997 NHS Economic Evaluation Database.

205. Surveillance mammography and stereotactic core breast biopsy for probably benign lesions: a cost comparison analysis

Surveillance mammography and stereotactic core breast biopsy for probably benign lesions: a cost comparison analysis Surveillance mammography and stereotactic core breast biopsy for probably benign lesions: a cost comparison analysis Surveillance mammography and stereotactic core breast biopsy for probably benign lesions: a cost comparison analysis Brenner R J, Sickles E A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each (...) abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Short-term unilateral surveillance mammography vs. stereotactic core needle breast biopsy (CNB), after routine screening mammography. Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis. Study population Patients with probably benign breast lesions detected during routine

1997 NHS Economic Evaluation Database.

206. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand

The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand Szeto K L, Devlin N J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Mammography screening. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Three different age groups of women were considered: 50-64, 50-69 and 45-64 years (women born between 1927 and 1980). Setting Tertiary care centre/hospital. The economic study was carried out in New Zealand. Dates to which data

1996 NHS Economic Evaluation Database.

207. Efficacy of screening mammography. A meta-analysis. (PubMed)

Efficacy of screening mammography. A meta-analysis. To determine the efficacy of screening mammography by age, number of mammographic views per screen, screening interval, and duration of follow-up.Literature review and meta-analysis. DATA IDENTIFICATION AND ANALYSIS: Literature search of English-language studies reported from January 1966 to October 31, 1993, using MEDLINE, manual literature review, and consultation with experts. A total of 13 studies were selected, and their results were (...) combined using meta-analytic techniques based on the assumption of fixed effects.The overall summary relative risk (RR) estimate for breast cancer mortality for women aged 50 to 74 years undergoing screening mammography compared with those who did not was 0.74 (95% confidence interval [CI], 0.66 to 0.83). The magnitude of the benefit in this age group was similar regardless of number of mammographic views per screen, screening interval, or duration of follow-up. In contrast, none of the summary RR

1995 JAMA

208. [Primary prevention trial of breast cancer by tamoxifen: the position of the French Society of Mammography and Breast Pathology]. (PubMed)

[Primary prevention trial of breast cancer by tamoxifen: the position of the French Society of Mammography and Breast Pathology]. 7995922 1995 01 13 2013 11 21 0368-2315 23 6 1994 Journal de gynecologie, obstetrique et biologie de la reproduction J Gynecol Obstet Biol Reprod (Paris) [Primary prevention trial of breast cancer by tamoxifen: the position of the French Society of Mammography and Breast Pathology]. 727-8 fre Clinical Trial Guideline Letter Randomized Controlled Trial Essai de

1995 Journal de gynecologie, obstetrique et biologie de la reproduction

209. UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. (PubMed)

UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. To compare one view (oblique) and two view (oblique and craniocaudal) mammography in breast cancer screening.Randomised controlled trial.Nine breast screening centres in England.40,163 women aged 50-64 attending their first breast screening examination.Women were randomised to have one view mammography, two view mammography, or two view mammography in which one view was read by one reader (...) and both views were read by another.Prevalence of cancer detected, recall rates, cost per cancer detected, and marginal cost per extra cancer detected.Two view mammography detected 24% more women with breast cancer (95% confidence interval 16% to 31%) than one view mammography. Prevalence of detected cancer was 6.84 with two view mammography and 5.52 per 1000 women with one view. The proportion of women recalled for assessment was 15% lower (95% confidence interval 6% to 23%) with two view (6.97%) than

Full Text available with Trip Pro

1995 BMJ

210. Approach to the utilization of screening mammography in two health regions

Approach to the utilization of screening mammography in two health regions Approach to the utilization of screening mammography in two health regions Approach to the utilization of screening mammography in two health regions Almazan C, Borras JM, de la Puente ML, Gimenez A, Granados A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) Almazan C, Borras JM, de la Puente ML, Gimenez A, Granados A. Approach to the utilization of screening mammography in two health regions. Barcelona: Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA). 1995 Authors' objectives To know the current utilization trends of screening mammography regarding the criteria of starting age of the screening, as defined in the Catalan Health Plan, and the activity of the mammographers. Methods:Cross-sectional study design. Authors

1995 Health Technology Assessment (HTA) Database.

211. Breast cancer screening through mammography. IPE-95/05 (Public report)

Breast cancer screening through mammography. IPE-95/05 (Public report) Breast cancer screening through mammography. IPE-95/05 (Public report) Breast cancer screening through mammography. IPE-95/05 (Public report) Conde Olasagasti J L, Gonzalez Enriquez J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Conde Olasagasti J L, Gonzalez (...) Enriquez J. Breast cancer screening through mammography. IPE-95/05 (Public report) Madrid: Agencia de Evaluacion de Tecnologias Sanitarias (AETS). 1995 Authors' objectives To summarise the available evidence on the use of mammography in mass screening for breast cancer. Authors' conclusions The available evidence regarding the efficacy of breast cancer screening by means of periodic mammography in women of 50 years of age or more, is solid and consistent, and is based fundamentally on the results

1995 Health Technology Assessment (HTA) Database.

212. Efficacy of screening mammography: a meta-analysis

Efficacy of screening mammography: a meta-analysis Efficacy of screening mammography: a meta-analysis Efficacy of screening mammography: a meta-analysis Kerlikowske K, Grady D, Rubin S M, Sandrock C, Ernster V L Authors' objectives To determine the efficacy of screening mammography by age, number of mammographic views per screen, screening interval and duration of follow-up. Searching MEDLINE was searched from January 1966 to October 31 1993 for English language publications using the terms (...) interventions included in the review Mammography screening for breast cancer. Reference standard test against which the new test was compared The review did not include any diagnostic accuracy studies that compared the performance of the index test with a reference standard of diagnosis. Participants included in the review Women aged 35 to 74 years were included. Outcomes assessed in the review The outcome measure was breast cancer mortality. How were decisions on the relevance of primary studies made

1995 DARE.

213. Mammography screening: an incremental cost effectiveness analysis of two-view versus one-view procedure in London

Mammography screening: an incremental cost effectiveness analysis of two-view versus one-view procedure in London Mammography screening: an incremental cost effectiveness analysis of two-view versus one-view procedure in London Mammography screening: an incremental cost effectiveness analysis of two-view versus one-view procedure in London Bryan S, Brown J, Warren R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each (...) abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Mammography screening by a single view (mediolateral-oblique) and two views (mediolateral-oblique plus craniocaudal) of each breast. Type of intervention Screening Economic study type Cost-effectiveness analysis Study population Women aged between 50 and 64. Setting Primary care/hospital. The economic study

1995 NHS Economic Evaluation Database.

214. Screening mammography in women aged 40-49 years: analysis of cost effectiveness

Screening mammography in women aged 40-49 years: analysis of cost effectiveness Screening mammography in women aged 40-49 years: analysis of cost effectiveness Screening mammography in women aged 40-49 years: analysis of cost effectiveness Rosenquist C J, Lindfors K K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed (...) critical assessment on the reliability of the study and the conclusions drawn. Health technology Programme of annual mammography. Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis Study population Hypothetical cohort of women aged between 45-49. Setting Primary care. The economic study was carried out in the USA. Dates to which data relate Cost data were in part collected from 1990 and 1994 studies. Price date was not specified. Source of effectiveness data

1994 NHS Economic Evaluation Database.

215. Breast cancer screening with mammography: overview of Swedish randomised trials. (PubMed)

Breast cancer screening with mammography: overview of Swedish randomised trials. Despite encouraging results from screening trials the efficacy of mammography in reducing mortality remains somewhat controversial. Five studies have been done in Sweden. This overview, based on 282,777 women followed for 5-13 years in randomised trials in Malmö, Kopparberg, Ostergötland, Stockholm, and Gothenburg, reveals a 24% (95% confidence interval 13-34%) significant reduction of breast cancer mortality among (...) those invited to mammography screening compared with those not invited. To avoid the potential risk of differential misclassification causes of death were assessed by an independent end-point committee after a blinded review of all fatal breast cancer cases. The mortality reduction was similar, irrespective of the end-point used for evaluation ("breast cancer as underlying cause of death" or "breast cancer present at death"). There was a consistent risk reduction associated with screening in all

1993 Lancet

216. The value of mammography screening in women under age 50 years

The value of mammography screening in women under age 50 years The value of mammography screening in women under age 50 years The value of mammography screening in women under age 50 years Eddy D M, Hasselblad V, McGivney W, Hendee W Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Mammography, clinical examination. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Women aged 40-49 years. Setting The study was carried out in the USA. Dates to which data relate Price related to 1984. Source of effectiveness data Review of studies. Modelling Epidemiological cohort model (model of survival and disease). Measure of benefits used in the economic analysis Life-years gained. Direct

1988 NHS Economic Evaluation Database.

217. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. (PubMed)

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. A randomised controlled trial to investigate the efficacy of mass screening with single-view mammography in reducing mortality from breast cancer was started in Sweden in 1977. 162 981 women aged 40 years or more and living in the counties of Kopparberg and Ostergötland were enrolled in the study

1985 Lancet

218. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. (PubMed)

Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Since 1975 four rounds of screening with modern mammography for breast cancer have been carried out among 30 000 Nijmegen women born before 1940. The results up to the end of 1981 shows that the odds ratio of screened vs unscreened subjects among women who died from breast cancer compared with women who did not, was 0.48 (95% confidence interval 0.23-1.00

1984 Lancet

219. Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. (PubMed)

Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. 5951878 1966 04 09 2016 10 17 0098-7484 195 9 1966 Feb 28 JAMA JAMA Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. 731-8 Shapiro S S Strax P P Venet L L eng Clinical Trial Journal Article Randomized Controlled Trial United States JAMA 7501160 0098-7484 AIM IM Adult Biopsy Breast Neoplasms diagnosis epidemiology Connecticut Female Follow-Up (...) Studies Humans Mammography Mass Screening Mastectomy Middle Aged Mortality New York Prognosis 1966 2 28 1966 2 28 0 1 1966 2 28 0 0 ppublish 5951878

1966 JAMA